Correlation Between Homology Medicines and Merus BV
Can any of the company-specific risk be diversified away by investing in both Homology Medicines and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Homology Medicines and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Homology Medicines and Merus BV, you can compare the effects of market volatilities on Homology Medicines and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Homology Medicines with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Homology Medicines and Merus BV.
Diversification Opportunities for Homology Medicines and Merus BV
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Homology and Merus is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Homology Medicines and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Homology Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Homology Medicines are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Homology Medicines i.e., Homology Medicines and Merus BV go up and down completely randomly.
Pair Corralation between Homology Medicines and Merus BV
If you would invest 109.00 in Homology Medicines on September 13, 2024 and sell it today you would earn a total of 0.00 from holding Homology Medicines or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.59% |
Values | Daily Returns |
Homology Medicines vs. Merus BV
Performance |
Timeline |
Homology Medicines |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Merus BV |
Homology Medicines and Merus BV Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Homology Medicines and Merus BV
The main advantage of trading using opposite Homology Medicines and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Homology Medicines position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.Homology Medicines vs. Passage Bio | Homology Medicines vs. Stoke Therapeutics | Homology Medicines vs. Adaptimmune Therapeutics Plc | Homology Medicines vs. Black Diamond Therapeutics |
Merus BV vs. Anebulo Pharmaceuticals | Merus BV vs. Adagene | Merus BV vs. Acrivon Therapeutics, Common | Merus BV vs. AnaptysBio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Valuation Check real value of public entities based on technical and fundamental data |